What You Will Learn
The FDA oversees clinical trials to ensure they are designed, conducted, analyzed and reported according to federal law and good clinical practice (GCP) regulations. Reviewing inspection observations and trends from 2021 can help clinical researchers determine common issues, highlight potential quality management gaps and identify improvement opportunities.
In this Expert Insights webinar, you’ll learn how to improve your quality systems and increase compliance as we will review FDA observations and trends from 2021 on:
- 483 Observations
- Warning Letters
- Seizures
- Trends & the R3 Draft
Register Now
Suggested For You
perspectives
January 29th, 2024
FDA Draft Guidance on Demonstrating Substantial Evidence Shines a Light on Confirmatory Evidence in Clinical Trials
perspectives
January 10th, 2024
Change Management and Preparing for Computerized System Audits is Critical to Ensure Positive Regulatory Inspections
perspectives
January 4th, 2024
Computer System Validation Needs Greater Attention When Preparing for an FDA Inspection
perspectives
November 30th, 2023
Good Laboratory Practice (GLP): A Validation Approach
perspectives
November 23rd, 2023
Meet These Four Expectations When Shifting SOPs in the Pharmaceutical Industry into Electronic Format
perspectives
November 21st, 2023
Quality in Clinical Trials Should be Owned by All Departments: Here’s Why
perspectives
October 31st, 2023
Computerised Systems and Electronic Data in Clinical Trials: New Guidelines and How to Reduce Risk
perspectives
October 19th, 2023
Corrective Action and Preventive Action (CAPA) Adoption for Massive Internal Improvements
perspectives
June 12th, 2023
The Role of Quality Assurance in Outsourcing: Ensuring Regulatory Compliance and Quality
perspectives
May 15th, 2023
Impact of ICH E6(R3) on the Future of Clinical Trials: What You Need to Know
perspectives
May 10th, 2023
Preparing for a GxP Audit Interview: Tips and Considerations for Auditors and Auditees
perspectives
April 14th, 2023
A Comprehensive Guide to Preparing for a Successful Good Laboratory Practice (GLP) Inspection